{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:05:50Z","timestamp":1758056750700,"version":"3.44.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.encep.2020.04.001","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T13:29:16Z","timestamp":1585920556000},"page":"S123-S124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S","title":["Epid\u00e9mie au nouveau coronavirus (SARS-CoV-2) et prescription de la clozapine: quelles mesures? Pourquoi?"],"prefix":"10.1016","volume":"46","author":[{"given":"A.","family":"Ben Dhia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hamzaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Mouaffak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"LEPONEX. Avis sur les M\u00e9dicaments","author":"Haute Autorit\u00e9 de Sant\u00e9 H.A.S","key":"10.1016\/j.encep.2020.04.001_bib0060"},{"key":"10.1016\/j.encep.2020.04.001_bib0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.schres.2018.05.046","article-title":"Prescriber and institutional barriers and facilitators of clozapine use: A systematic review","volume":"201","author":"Verdoux","year":"2018","journal-title":"Schizophr Res"},{"issue":"3","key":"10.1016\/j.encep.2020.04.001_bib0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/YIC.0000000000000162","article-title":"Clozapine usage increases the incidence of pneumonia compared with risperidone and the general population: a retrospective comparison of clozapine, risperidone, and the general population in a single hospital over 25\u00a0months","volume":"32","author":"Stoecker","year":"2017","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2020.04.001_bib0075","article-title":"Antipsychotic medication exposure, clozapine, and pneumonia: results from a self-controlled study","author":"Rohde","year":"2019","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"10.1016\/j.encep.2020.04.001_bib0080","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.psym.2018.07.001","article-title":"Clozapine-associated aspiration pneumonia: case series and review of the literature: reply","volume":"60","author":"Gurrera","year":"2019","journal-title":"Psychosomatics"},{"key":"10.1016\/j.encep.2020.04.001_bib0085","doi-asserted-by":"crossref","DOI":"10.1136\/jclinpath-2019-206235","article-title":"Clinical and laboratory characteristics of clozapine-treated patients with schizophrenia referred to a national immunodeficiency clinic reveals a B-cell signature resembling common variable immunodeficiency (CVID)","author":"Ponsford","year":"2020","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.encep.2020.04.001_bib0090","first-page":"1","article-title":"Clozapine is associated with secondary antibody deficiency","author":"Ponsford","year":"2018","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2020.04.001_bib0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","article-title":"Elevated clozapine levels associated with infection: A systematic review","volume":"192","author":"Clark","year":"2018","journal-title":"Schizophr Res"},{"issue":"8","key":"10.1016\/j.encep.2020.04.001_bib0100","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4088\/JCP.v65n0818a","article-title":"Respiratory infections rather than antibiotics may increase clozapine levels: a critical review of the literature","volume":"65","author":"de Leon","year":"2004","journal-title":"J clin psychiat"},{"key":"10.1016\/j.encep.2020.04.001_bib0105","unstructured":"Notice on Strengthening the Treatment and Management of Patients with Severe Mental Disorders during the Outbreak of the New Coronary Pneumonia (in Chinese) [Internet]. [cited February 18th, 2020]. Available from: http:\/\/wwwnhcgovcn\/jkj\/s3577\/202002\/f315a6bb2955474c8ca0b33b0c356a32shtml."},{"key":"10.1016\/j.encep.2020.04.001_bib0055","unstructured":"PUI-CH. Charles Perrens. M\u00e9dicaments utilis\u00e9s en psychiatrie\u2013Conduites \u00e0 tenir en cas de patients suspects et\/ou confirm\u00e9s COVID+, (27\/03\/2020). Available from: https:\/\/www.groupedeveillecovid.fr\/blog\/2020\/04\/01\/medicaments-utilises-psychiatrie-conduites-a-tenir-cas-de-patients-suspects-etou-confirmes-covid\/."}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700620300683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700620300683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:37:48Z","timestamp":1757957868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700620300683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0013700620300683"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2020.04.001","relation":{},"ISSN":["0013-7006"],"issn-type":[{"type":"print","value":"0013-7006"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epid\u00e9mie au nouveau coronavirus (SARS-CoV-2) et prescription de la clozapine: quelles mesures? Pourquoi?","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2020.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}